Poll Shows 80 Percent of Older Voters Concerned Prescription Drug Reform Will Hurt Drug Innovation
Sort by
Date
Items per page
-
62 percent of Biden voters want to replace both candidates on the ballot: Poll
Roughly 6 in 10 voters backing President Biden say they’d replace both the incumbent and his rival former President Trump on the 2024 ballot if they could, polling released Wednesday shows. A Pew Research report found 62 percent of Biden ...The Hill - Politics - Joe Biden -
The New Drug Threat
An investigation into the supply of illegal synthetic opioid drugs called nitazenes.BBC News - Top stories -
Man jailed for trying to smuggle drugs into country
Yahoo News - World -
Biden grants clemency to 16 nonviolent drug offenders
"America is a nation founded on the promise of second chances," President Biden said in a statement.CBS News - Politics - Joe Biden -
How one state is trying to make weight loss drugs cheaper
Weight loss drugs aren't covered by insurance for North Carolina's state employees. The state is negotiating with drugmakers Eli Lilly and Novo Nordisk to try to lower the costs.NBC News - Top stories -
Sanders launches investigation into 'unacceptable' diabetes, weight loss drug prices
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, ...The Hill - Politics -
Insurers scale back reimbursements for drugs used for weight loss
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.NBC News - Top stories -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
Zuckerberg defends Meta’s AI spending spree as shares tumble
Parent of Facebook and Instagram reports better than expected quarterly revenue but raises capex guidanceFinancial Times - Business -
EveryONE Medicines: Designing Drugs for Rare Diseases, One at a Time
Khosla Ventures, GV, Third Rock Ventures back effort to create medicines for individual patients with rare central nervous system diseases.The Wall Street Journal - World -
For Beaten-Down Maker of Alzheimer's Drug, Good Enough Will Do
In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys has Wall Street giving Biogen another chance.The Wall Street Journal - World -
BHP plans £31bn bid for Anglo American but attracts ire from South Africa and shareholders
Legal & General and Abrdn criticise offer as undervaluing UK-listed minerFinancial Times - Business -
Sanders locks onto next drug pricing target: Ozempic
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Sanders locks onto next drug pricing target: Ozempic After successfully getting manufacturers to lower the prices of insulin and inhalers, Sen. Bernie Sanders ...The Hill - Politics -
AbbVie’s first-quarter results top expectations as arthritis drugs fuel growth
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.MarketWatch - Business -
NBC News poll: One in 4 voters could change their minds on presidential race
A quarter of all voters are still open to changing their minds on who they'll vote for in the 2024 presidential race, per the latest NBC News national poll.NBC News - Top stories -
NBC News poll: One in 4 voters could change their minds on presidential race
A quarter of all voters are still open to changing their minds on who they'll vote for in the 2024 presidential race, per the latest NBC News national poll.NBC News - Politics -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up
Alzheimer's drug Leqembi brought in approximately $19 million in sales for the quarter, up from the $10 million the drug generated last year.CNBC - Business -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - World -
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Malaria is still a significant public health challenge in Kenya, but an important pilot of the world’s first malaria vaccine may helpABC News - Health -
What do weight loss drugs mean for a diet industry built on eating less and exercising more?
New weight loss drugs are reshaping a dieting industry built on eating less and exercising moreABC News - Health -
Cost of developing new drugs may be far lower than industry claims, trial reveals
Exclusive: MSF calls for transparency after its bill for a trial of TB treatment came to a fraction of the billions claimed by pharmaceutical companies. Doctors have for the first time released details of their spending on a major clinical trial, ...The Guardian - World -
Bristol Myers Squibb shares fall amid sluggish sales of some newer drugs
Bristol Myers Squibb shares fell early Thursday after the company reported better-than-expected first-quarter results but said it would cut about 2,200 jobs this year.MarketWatch - Business -
A US citizen facing drug charges in Russia appears in court. His case was adjourned until mid-May
A U.S. citizen arrested on drug charges in Moscow amid soaring Russia-U.S. tensions has appeared in court and had his case adjourned until mid-MayABC News - World -
First round of North Macedonia's presidential polls shows big shift towards center-right opposition
Near-complete results from North Macedonia’s first round of presidential polls confirm a strong shift towards a candidate backed by the country’s center-right oppositionABC News - World -
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal SoriotFinancial Times - Business - China -
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
Continent’s drugmakers need to pay up to attract and retain talent, says Pascal SoriotFinancial Times - Business - China -
A reformed stock market would unleash Britain’s growth
Keeping growth companies onshore would boost the FTSE and the UK economyFinancial Times - World -
Reform UK’s unusual structure with Nigel Farage in the middle
Farage insists he is not a politician — but within the rightwing populist party, he is kingmakerFinancial Times - World -
Reform UK’s unusual structure with Nigel Farage in the middle
Farage insists he is not a politician — but within the rightwing populist party, he is kingmakerFinancial Times - Business -
Biden gains on Trump in series of polls
President Biden is gaining on former President Trump in a series of polls, tying Trump in the race in a new Quinnipiac poll released Wednesday and lending a sense of momentum to his campaign. In the aggregate polling kept by The Hill and Decision ...The Hill - Politics - Joe Biden -
Michelin Backs Targets After Weaker Demand Hurts Sales
Sales for the French tire manufacturer fell to €6.64 billion from €6.96 billion in the first quarter of last year.The Wall Street Journal - Business -
108 arrested at Emerson College protest, 4 Boston police officers hurt
Boston Police arrested more than 100 people as they cleared out pro-Palestinian protesters and their encampment from Emerson College early Thursday morning.CBS News - Top stories -
India’s farmers are up in arms again. Will it hurt Modi’s reelection campaign?
While the protestors are beginning to up the ante by blocking railway tracks, the agitation this time seems a pale shadow of their movement in 2020.CNBC - Business -
More Americans have little, no confidence in Netanyahu: Poll
An increasing number of Americans have little to no trust in Israeli Prime Minister Benjamin Netaynahu's handling of world affairs, according to a new poll. A new report, issued Thursday by Pew Research Center, found 53 percent of U.S. adults said ...The Hill - Politics -
US economic growth falls short of expectations with 1.6 percent annualized gain
U.S. economic growth dipped below 2 percent during the first quarter for the first time in more than a year and a half, according to a new government reading released Thursday. Gross domestic product (GDP) grew at an annualized rate of 1.6 percent ...The Hill - Politics -
Battery storage costs could fall up to 40 percent by 2030: IEA
A steep decline in battery costs will be the primary driver in the transition from fossil fuels to renewable energy in the years ahead, the International Energy Agency (IEA) projected. Battery costs have declined more than 90 percent in about a ...The Hill - Politics